Stockreport

XBiotech Identifies “Super Bloods” for the Development of a True Human™ COVID-19 Therapy

XBiotech Inc.  (XBIT) 
Last xbiotech inc. earnings: 8/9 03:01 pm Check Earnings Report
US:NASDAQ Investor Relations: xbiotech.com/about/investors.html
PDF Donors with Potent Natural Immunity Against the Virus are Identified as the Starting Point for XBiotech’s Drug Development Program to Treat COVID-19 AUSTIN, Texas, May [Read more]